BioSpace News Archive

Policy

Clinical trial waiver in China opens door to 2022 registration filing for ALK’s dust mite allergy tablet

ALK announced that it expects to submit a registration application in China for its house dust mite sublingual allergy immunotherapy tablet already in 2022.

March 3, 2022
·
2 min read
BioMidwest

Acibadem Group Purchases Second MRIdian® System for Acibadem Altunizade Hospital in Istanbul

ViewRay, Inc. announced that the Acibadem Group, one of the leading private healthcare service institutions in Turkey, has purchased a second MRIdian MRI-guided radiation therapy system for installation at the Acibadem Altunizade Hospital in Istanbul, Turkey.

March 3, 2022
·
6 min read
Business

BIOLASE to Report Fourth Quarter and Full Year 2021 Results on March 17, 2022

BIOLASE, Inc. announced that it will release fourth quarter and full-year 2021 financial and operating results on Thursday, March 17, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m.

March 3, 2022
·
2 min read
Business

Adrestia Appoints Robert Johnson as Chief Executive Officer

Adrestia Therapeutics today announced the appointment of life sciences executive Robert Johnson as Chief Executive Officer.

March 3, 2022
·
6 min read
Magellan Rx Management Releases Clinical Insights on the Use of Psychedelics in Treating Mental Health Conditions

Magellan Rx Management today released its Clinical Insights publication titled Therapeutic Psychedelics: an Emerging Frontier in Mental Health.

March 3, 2022
·
3 min read
Business

NeonMind and BioScript Solutions Announce Strategic Partnership Expanding NeonMind’s Specialty Clinic Network for Interventional Psychiatry Treatments

NeonMind Biosciences Inc. announced today a strategic partnership with BioScript Solutions, a Canadian leader in specialty care.

March 3, 2022
·
5 min read
First Wave BioPharma Announces Poster Presentation at the 2022 Digestive Disease Week (DDW) Conference

First Wave BioPharma, Inc., announced today that an abstract entitled, “Niclosamide Enemas, A Safe And Effective Treatment In Mild To Moderate Ulcerative Proctitis/Proctosigmoiditis.

March 3, 2022
·
7 min read
Genetown

Orchard Therapeutics to Present at Multiple Investor Conferences in March 2022

Orchard Therapeutics, a global gene therapy leader, announced that members of the management team will present at the following investor conferences.

March 3, 2022
·
2 min read
Business

Clearside Biomedical Appoints Benjamin R. Yerxa, Ph.D. to its Board of Directors

Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, announced that Benjamin R. Yerxa, Ph.D., has been appointed to the Company’s Board of Directors, effective March 2, 2022.

March 3, 2022
·
5 min read
Biotech Beach

Aurora Spine Corporation Announces Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device

Aurora Spine Corporation, a manufacturer of innovative spinal implants announced that it has completed the world’s first DEXA-C implantation at Cypress Pointe Surgical Hospital in Louisiana, where the implant density was directly matched with the patient’s bone quality.

March 3, 2022
·
5 min read